Guardant Health Overview
Guardant Health Target Price
Analysts' 12-month price predictions for GH.
Get informed when a big investor buys or sells
+ FollowShare Price
$127.03
Average Target Price
$132.38
4.2% upside
4.2% upside13 analysts in the last 4 months
High: $160 | Low: $110
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-27 | BTIG | $160 | 26% upside |  |
| 2026-05-26 | BTIGMark Massaro | $155 | 22% upside | |
| 2026-05-21 | Piper Sandler | $127 | 0% upside | |
| 2026-05-12 | Piper SandlerDavid Westenberg | $135 | 6.3% upside | |
| 2026-04-14 | BarclaysLuke Sergott | $115 |  9.5% downside | |
| 2026-02-24 | Piper Sandler | $130 | 2.3% upside | |
| 2026-02-23 | Raymond James | $129 | 1.6% upside | |
| 2026-02-20 | Evercore ISI | $110 | 13.4% downside | |
| 2026-02-20 | BTIG | $145 | 14.1% upside | |
| 2026-02-20 | Stifel Nicolaus | $130 | 2.3% upside | |
| 2026-02-20 | Canaccord Genuity | $135 | 6.3% upside | |
| 2026-02-20 | Barclays | $130 | 2.3% upside | |
| 2026-02-17 | Robert W. BairdCatherine Schulte | $120 | 5.5% downside | |
| 2026-01-30 | UBS | $175 | 37.8% upside | |
| 2026-01-26 | Guggenheim | $135 | 6.3% upside | |
| 2026-01-09 | Stifel Nicolaus | $120 | 5.5% downside | |
| 2026-01-09 | Mizuho Securities | $135 | 6.3% upside | |
| 2026-01-05 | GuggenheimSubbu Nambi | $115 | 9.5% downside | |
| 2026-01-05 | Evercore ISIVijay Kumar | $105 | 17.3% downside | |
| 2025-12-22 | Canaccord Genuity | $125 | 1.6% downside | |
| 2025-12-17 | Mizuho Securities | $120 | 5.5% downside | |
| 2025-12-15 | Leerink Partners | $155 | 22% upside | |
| 2025-12-15 | Wells FargoBrandon Couillard | $120 | 5.5% downside | |
| 2025-12-15 | Barclays | $120 | 5.5% downside | |
| 2025-12-12 | BTIG | $140 | 10.2% upside | |
| 2025-12-01 | Morgan StanleyTejas Savant | $130 | 2.3% upside | |
| 2025-10-30 | UBSDan Leonard | $110 | 13.4% downside | |
| 2025-10-30 | BTIGMark Massaro | $100 | 21.3% downside | |
| 2025-10-30 | Mizuho SecuritiesBradley Bowers | $100 | 21.3% downside | |
| 2025-10-30 | Canaccord GenuityKyle Mikson | $100 | 21.3% downside | |
| 2025-10-30 | Barclays | $85 | 33.1% downside | |
| 2025-10-22 | Piper Sandler | $90 | 29.2% downside | |
| 2025-10-02 | Barclays | $70 | 44.9% downside | |
| 2025-09-26 | Canaccord GenuityKyle Mikson | $75 | 41% downside | |
| 2025-09-25 | Stifel Nicolaus | $70 | 44.9% downside | |
| 2025-09-25 | BTIGMark Massaro | $80 | 37% downside | |
| 2025-09-25 | Stifel NicolausDaniel Arias | $73 | 42.5% downside | |
| 2025-09-25 | Wolfe ResearchDoug Schenkel | $75 | 41% downside | |
| 2025-06-25 | China Renaissance Securities (US) Inc.Tempus AI | $70 | 44.9% downside | |
| 2025-03-05 | Morgan Stanley | $52 | 59.1% downside | |
| 2024-08-21 | UBSDan Leonard | $40 | 68.5% downside | |
| 2024-08-08 | Craig-HallumBill Bonello | $37 | 70.9% downside | |
| 2024-08-08 | JefferiesTycho Peterson | $40 | 68.5% downside | |
| 2024-07-29 | BTIGMark Massaro | $50 | 60.6% downside | |
| 2024-06-28 | GuggenheimSubbu Nambi | $36 | 71.7% downside | |
| 2024-06-04 | Canaccord GenuityKyle Mikson | $38 | 70.1% downside | |
| 2024-06-03 | JefferiesTycho Peterson | $32 | 74.8% downside | |
| 2024-05-23 | BTIGMark Massaro | $45 | 64.6% downside | |
| 2024-05-22 | Canaccord GenuityKyle Mikson | $30 | 76.4% downside | |
| 2024-04-24 | Craig-HallumChase Knickerbocker | $28 | 78% downside | |